RSCM
CNTA

Rock Springs Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Rock Springs Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14M Buy
351,828
+27,813
+9% +$711K 0.82% 39
2025
Q4 		$8.1M Buy
324,015
+254,775
+368% +$6.45M 0.42% 55
2025
Q3 		$1.68M Buy
+69,240
New +$1.23M 0.1% 80

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Rock Springs Capital Management's CNTA Position: Q1 2026 in Review

Rock Springs Capital Management increased its Centessa Pharmaceuticals (CNTA) stake by 8.6% in Q1 2026, buying an estimated $711K and bringing the position to 351,828 shares worth $14M. The position accounts for 0.82% of the portfolio, ranked #39.

Rock Springs Capital Management first reported a position in CNTA in Q3 2025 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Rock Springs Capital Management held 351,828 shares of Centessa Pharmaceuticals worth $14M as of Q1 2026.
  • Rock Springs Capital Management bought 27,813 Centessa Pharmaceuticals shares in Q1 2026, an estimated $711K.
  • Centessa Pharmaceuticals made up 0.82% of Rock Springs Capital Management's portfolio in Q1 2026, its #39 holding.
  • Rock Springs Capital Management first reported a position in Centessa Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Rock Springs Capital Management's 13F filing for Q1 2026, filed 15 May 2026.